Tested Applications
| Positive WB detected in | A549 cells, mouse heart tissue, HeLa cells, HepG2 cells, Jurkat cells, MCF-7 cells, NCI-H1299 cells |
| Positive IP detected in | HeLa cells |
| Positive IHC detected in | human colon cancer tissue, human colon tissue, human liver cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive IF/ICC detected in | HeLa cells, MCF-7 cells |
| Positive FC (Intra) detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:2000-1:12000 |
| Immunoprecipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
| Immunohistochemistry (IHC) | IHC : 1:800-1:3200 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.25 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10320-1-AP targets TCP1 alpha in WB, IHC, IF/ICC, FC (Intra), IP, CoIP, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0389 Product name: Recombinant human TCP1 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 277-553 aa of BC000665 Sequence: KILATGANVILTTGGIDDMCLKYFVEAGAMAVRRVLKRDLKRIAKASGATILSTLANLEGEETFEAAMLGQAEEVVQERICDDELILIKNTKARTSASIILRGANDFMCDEMERSLHDALCVVKRVLESKSVVPGGGAVEAALSIYLENYATSMGSREQLAIAEFARSLLVIPNTLAVNAAQDSTDLVAKLRAFHNEAQVNPERKNLKWIGLDLSNGKPRDNKQAGVFEPTIVKVKSLKFATEAAITILRIDDLIKLHPESKDDKHGSYEDAVHSGA Predict reactive species |
| Full Name | t-complex 1 |
| Calculated Molecular Weight | 60 kDa |
| Observed Molecular Weight | 55-60 kDa |
| GenBank Accession Number | BC000665 |
| Gene Symbol | TCP1 |
| Gene ID (NCBI) | 6950 |
| RRID | AB_10694136 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P17987 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
0
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for TCP1 alpha antibody 10320-1-AP | Download protocol |
| IF protocol for TCP1 alpha antibody 10320-1-AP | Download protocol |
| IHC protocol for TCP1 alpha antibody 10320-1-AP | Download protocol |
| IP protocol for TCP1 alpha antibody 10320-1-AP | Download protocol |
| WB protocol for TCP1 alpha antibody 10320-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TCP1 alpha Polyclonal antibody (Cat# 10320-1-AP) has 13 citations across journals including Cell, Molecular Cell, Journal of Clinical Investigation, Science Advances, Signal Transduction and Targeted Therapy, Journal of Cell Biology, Cell Signaling, Frontiers in Endocrinology, Frontiers in Cell and Developmental Biology, Pharmaceutics, Journal of Agricultural and Food Chemistry, Journal of Alzheimer's Disease, and Virology. Research fields span protein chaperone biology, cilia assembly/disassembly, acute myeloid leukemia, multiple sclerosis, NAFLD, breast cancer, tau pathology, and viral replication.
| Species | Application | Title |
|---|---|---|
Signal Transduct Target Ther Albumosomes formed by cytoplasmic pre-folding albumin maintain mitochondrial homeostasis and inhibit nonalcoholic fatty liver disease | ||
J Clin Invest ANKRD55 is a key regulator of T cell inflammation in multiple sclerosis
| ||
Sci Adv EIF3D safeguards the homeostasis of key signaling pathways in human primed pluripotency | ||
Pharmaceutics The Molecular Chaperone TCP1 Affects Carcinogenicity and Is a Potential Therapeutic Target for Acute Myeloid Leukemia
|

























